The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms

Cancer Research

Volumn 70, Issue 8, 2010, Pages 3402-3410

  Cho, Sool Yeon ^a   Xu, Mingjiang ^a,b   Roboz, John ^a   Lu, Min ^a   Mascarenhas, John ^a   Hoffman, Ronald ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Myeloproliferative Disorder Research Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; GELATINASE A; GELATINASE B; LEUKOCYTE ELASTASE; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CD34 SELECTION; CELL MIGRATION; CONTROLLED STUDY; EPIGENETICS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION;

ANTIGENS, CD34; CASE-CONTROL STUDIES; CATHEPSIN G; CELL MOVEMENT; CHEMOKINE CXCL12; EPIGENESIS, GENETIC; HUMANS; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 77951067623     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3977     Document Type: Article

References (35)

1. Hoffman R, Xu M, Finazzi G, Barbui T. The polycythemias. In: Hoffman R, Benz E, Jr., Shattil S, et al, editors. Hematology: Basic Principles and Practice. 5th Edition Philadelphia (PA): Churchill Livingstone; 2008, p. 1073-1108
2. Barosi G, Viarengo G, Pecci A, et al. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001;98:3249-3255
3. Levine RL, Gilliland DG. Myeloproliferative disorders. Blood 2008;112:2190-2198
4. Papayannopoulou T, Scadden DT. Stem-cell ecology and stem cells in motion. Blood 2008;111:3923-3930
5. + cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 2005;105:4508-4515
6. Migliaccio AR, Martelli F, Verrucci M, et al. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Exp Hematol 2008;36:158-171
7. Lataillade JJ, Pierre-Louis O, Hasselbalch HC, et al. French INSERM and the European EUMNET networks on myelofibrosis. Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 2008;112:3026-3035
8. + cells of patients with myelofibrosis with myeloid metaplasia. Blood Cells Mol Dis 2007;38:280-286
9. + cells from patients with primary myelofibrosis. Stem Cells 2008;26:1920-1930.
10. + cells into peripheral blood in myeloproliferative disorders. Blood 2006;107:3676-3682
11. Sweeney EA, Papayannopoulou T. Increase in circulating SDF-1 after treatment with sulfated glycans. The role of SDF-1 in mobilization. Ann N Y Acad Sci 2001;938:48-52.
12. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007;110:1092-1097 (Pubitemid 47281402)
13. Xu M, Bruno E, Chao J, et al. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis. Blood 2005;105:1699-1705 (Pubitemid 40223693)
14. Delgado MB, Clark-Lewis I, Loetscher P, et al. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol 2001;31:699-707. (Pubitemid 32237105)
15. Valenzuela-Fernandez A, Planchenault T, et al. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (CXCL12)/CXCR4 binding and functions by amino-terminal processing of CXCL12 and CXCR4. J Biol Chem 2002;277:15677-15689 (Pubitemid 34967841)
16. Aivado M, Spentzos D, Germing U, et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci U S A 2007;104:1307-1312 (Pubitemid 46184000)
17. Ajami K, Pitman MR, Wilson CH, et al. Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett 2008;582:819-825
18. De La Luz Sierra M, Yang F, Narazaki M, et al. Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity. Blood 2004;103:2452-2459 (Pubitemid 38392993)
19. Davis DA, Singer KE, De La Luz Sierra M, et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulation. Blood 2005;105:4561-4568 (Pubitemid 40807271)
20. McQuibban GA, Butler GS, Gong JH, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001;276:43503-43508 (Pubitemid 37383907)
21. + cells from patients with idiopathic myelofibrosis. Cancer Res 2007;67:6417-6424
22. Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 2009;23:43-52.
23. Boldajipour B, Mahabaleshwar H, Kardash E, et al. Control of chemokine-guided cell migration by ligand sequestration. Cell 2008;132:463-473 (Pubitemid 351191997)
24. Saitoh H, Shibata A. Serum G-CSF levels in primary myelofibrosis and chronic neutrophilic leukemia as estimated by the highly sensitive chemiluminescence enzyme immunoassay (CLEIA). Leuk Lymphoma 1996;22:515-517 (Pubitemid 26341019)
25. Ciurea SO, Merchant D, Mahmud N, et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 2007;110:986-993 (Pubitemid 47267438)
26. Christopherson KW II, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cellderived factor-1 α-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002;169:7000-7008 (Pubitemid 36899288)
27. Proost P, Struyf S, Schols D, et al. Processing by CD26/ dipeptidylpeptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α. FEBS Lett 1998;432:73-76 (Pubitemid 28360743)
28. Ransohoff RM. Snip-snip, kill-kill: truncated SDF-1 and HIV-associated neurodegeneration. Nat Neurosci 2003;6:1009-1011
29. Vergote D, Butler GS, Ooms M, et al. Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Natl Acad Sci U S A 2006;103:19182-19187 (Pubitemid 350002847)
30. Zhang K, McQuibban GA, Silva C, et al. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003;6:1064-1071 (Pubitemid 37186198)
31. + progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue. Ann Hematol 2002;81:86-89
32. Barosi G, Rosti V, Massa M, et al. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 2004;124:618-625 (Pubitemid 38297094)
33. Christopher MJ, Liu F, Hilton MJ, Long F, Link DC. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 2009;114:1331-1339
34. + cells by treatment with chromatin-modifying agents. Cancer Res 2009;69:7612-7618
35. Stefanidakis M, Karjalainen K, Jaalouk DE, et al. Role of leukemia cell invadosome in extramedullary infiltration. Blood 2009;114:3008-3017